Cash flow Statement (Quarterly, GAAP
in millions $) |
(Sep 30 2023) 9 Months |
(Jun 30 2023) 6 Months |
(Mar 31 2023) 3 Months |
(Dec 31 2022) 12 Months |
(Sep 30 2022) 9 Months |
Income |
-122.02 |
-78.78 |
-37.81 |
-197.72 |
-142.68 |
Depreciation & amortization |
0.39 |
0.27 |
0.15 |
0.62 |
0.45 |
Amortization of Other Assets |
1.31 |
0.77 |
0.50 |
2.11 |
1.61 |
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense
|
- |
- |
- |
- |
- |
Restructuring & Impairment Charges |
- |
- |
- |
- |
- |
Provision for Loan, Lease, and Other Losses |
- |
- |
- |
- |
- |
Increase (Decrease) in Inventories |
-0.11 |
- |
- |
- |
- |
Research and Development in Process |
- |
- |
- |
- |
- |
Gain (Loss) on Disposition of Assets |
- |
- |
- |
- |
- |
Share-based Compensation |
20.44 |
14.30 |
7.05 |
24.13 |
17.48 |
Income (Loss) from Equity Method Investments |
- |
- |
- |
- |
- |
Paid-in-Kind Interest |
2.68 |
1.77 |
0.88 |
3.48 |
2.59 |
Interest Expense Other |
- |
- |
- |
- |
- |
Fair Value Adjustment Of Convertible Promissory Notes |
- |
- |
- |
- |
- |
Other Expenses |
- |
- |
- |
- |
- |
Accrued Interest On Revenue Interest Financing Liability |
16.27 |
10.55 |
5.15 |
8.35 |
2.66 |
Increase Decrease In Clinical Accrued Trial Expenses |
0.66 |
0.10 |
0.05 |
-0.31 |
-0.29 |
Income taxes |
- |
- |
- |
- |
- |
Losses/ -gains on Investments net |
- |
- |
- |
- |
- |
Accounts Receivable |
- |
- |
- |
- |
- |
Increase (Decrease) in Accounts Payable and Accrued Liabilities |
-3.86 |
-8.45 |
-11.30 |
8.68 |
4.76 |
Increase (Decrease) in Interest Payable, Net |
0.10 |
0.07 |
0.06 |
0.38 |
0.21 |
Deferred Revenue and Customer Advances and Deposits |
- |
- |
- |
- |
- |
Increase (Decrease) in Prepaid Expense and Other Assets |
-7.81 |
-3.63 |
-5.14 |
-1.86 |
2.29 |
Other Working Capital |
-3.45 |
- |
- |
-0.12 |
-0.46 |
Other Noncash Income (Expense) |
1.47 |
1.16 |
0.76 |
1.33 |
1.13 |
Other net |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Operating Activities |
0.15 |
- |
- |
-1.40 |
-1.26 |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Operating Activities |
-93.78 |
-61.87 |
-39.67 |
-146.53 |
-105.83 |
Capital Expenditures |
-1.16 |
-0.22 |
-0.21 |
-1.04 |
-0.63 |
Sale of Capital Items |
- |
- |
- |
- |
- |
Short-term Investments Proceeds |
- |
- |
- |
- |
- |
Short-term Investments Acq. |
- |
- |
- |
- |
- |
Real Estate Investments |
- |
- |
- |
- |
- |
Restricted Cash and Investments Increase (Decrease) |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Loans |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Deposits |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investments |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Federal Reserve and Federal Home Loan Bank |
- |
- |
- |
- |
- |
Payments to Acquire in Process Research and Development |
- |
- |
- |
- |
- |
Interest in Subsidiaries and Affiliates |
- |
- |
- |
- |
- |
Sale of businesses |
- |
- |
- |
- |
- |
Accounts payable |
- |
- |
- |
- |
- |
Receivables |
- |
- |
- |
- |
- |
Payments for (Proceeds from) Other Investing Activities |
- |
- |
- |
- |
- |
Other Net |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Net Cash flow from
Investing Activities |
-1.16 |
-0.22 |
-0.21 |
-1.04 |
-0.63 |
Short-term debt Net |
- |
- |
- |
- |
- |
Other borrowing transactions |
- |
- |
- |
- |
- |
Long-term debt - borrowings |
- |
- |
- |
- |
- |
Long-term debt - repayments |
- |
- |
- |
- |
- |
Federal Home Loan Bank and Federal Funds |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Comm. Stock |
0.12 |
0.11 |
- |
- |
- |
Partnership and Parent Transactions |
- |
- |
- |
- |
- |
Issuances/ -repurchases
of Pref. Stock |
- |
- |
- |
- |
- |
Deposits, Annuities, Contract Holders Funds |
- |
- |
- |
- |
- |
Other financing activities net |
- |
- |
- |
- |
- |
Other net |
155.46 |
155.46 |
14.07 |
24.60 |
24.60 |
Proceeds From Underwritten Public Offering Net |
- |
- |
- |
- |
- |
Net Proceeds From Revenue Interest Financing Transaction |
- |
- |
- |
95.45 |
95.45 |
Payments of Dividends, Preferred Stock and Preference Stock |
- |
- |
- |
- |
- |
Dividends paid |
- |
- |
- |
- |
- |
Net Cash flow from
Financing Activities |
155.59 |
155.57 |
14.07 |
120.04 |
120.04 |
Effect of exchange rate on cash flow |
- |
- |
- |
- |
- |
Discontinued operations |
- |
- |
- |
- |
- |
Free
Cash Flow |
-94.94 |
-62.09 |
-39.88 |
-147.57 |
-106.46 |
Total Cash Flow |
60.65 |
93.49 |
-25.81 |
-27.53 |
13.58 |
Cash & cash equiv. at beg.
of the Year |
- |
- |
- |
- |
- |
Cash & cash equivalents at
end of period |
- |
- |
- |
- |
- |
Cash Interests paid |
- |
- |
- |
- |
- |
Cash Income taxes paid |
- |
- |
- |
- |
- |